Indo US Bio-TechNSE:INDOUS -1.49%69 Days Payable is 2.22 as of Mar. 2026, which is 96% below its 10-year median of 50.63. GuruFocus rates NSE:INDOUS with a GF Score™ of 69/100 and a GF Value™ of ₹311.42 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 244 Agriculture companies, Indo US Bio-Tech ranks worse than 98.77% on this metric.
The historical rank and industry rank for Indo US Bio-Tech's Days Payable or its related term are showing as below:
NSE:INDOUS'
s Days Payable Range Over the Past 10 Years
Min: 3.66 Med: 50.63 Max: 114.75
Current: 4.11
During the past 13 years, Indo US Bio-Tech's highest Days Payable was 114.75. The lowest was 3.66. And the median was 50.63.
NSE:INDOUS's Days Payable is ranked worse than 98.77% of 244
companies
in the Agriculture industry
Industry Median: 72.7
vs NSE:INDOUS: 4.11
Indo US Bio-Tech's Days Payable
declined
from Mar. 2025 (6.63) to Mar. 2026 (2.22).
It may suggest that Indo US Bio-Techaccelerated paying its suppliers.
Indo US Bio-Tech Days Payable Related Terms
Indo US Bio-Tech Days Payable Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: Days Payable Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Days Payable vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Days Payable distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Indo US Bio-Tech's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a Days Payable of 2.22 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indo US Bio-Tech and its competitors. This is 96% below median its historical median of 50.63. Over the past decade, Indo US Bio-Tech's Days Payable has ranged from 3.66 to 114.75. According to the industry distribution chart, Indo US Bio-Tech ranks #241 out of 244 companies in the Agriculture industry, placing it in the top 98.8%.
Is Indo US Bio-Tech's Days Payable too high?
Indo US Bio-Tech's current Days Payable of 2.22 is 96% below median its 10-year median of 50.63. Over the past 10 years, this metric has ranged from a low of 3.66 to a high of 114.75. The Agriculture industry median Days Payable is 72.70. Indo US Bio-Tech's value of 2.22 is 96.9% below this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #241 out of 244 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Days Payable compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #241 out of 244 companies for Days Payable. This places Indo US Bio-Tech in the lower half of its industry. The industry median Days Payable is 72.70. Indo US Bio-Tech's value of 2.22 is 96.9% below this benchmark. Historically, Indo US Bio-Tech's own Days Payable has ranged from 3.66 to 114.75 over the past decade. While the company's 10-year median is 50.63 vs. the industry median of 72.70, Indo US Bio-Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Agriculture company?
The median Days Payable among Agriculture companies is 72.70, based on 244 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Days Payable of 2.22 is 96.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Days Payable is 72.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Days Payable is 2.22, which is 96% below median its own 10-year median of 50.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹311.42, compared to a current price of ₹87.82 — trading 71.8% below its estimated fair value. The current Days Payable is 2.22, which is 96% below median its 10-year median of 50.63 and 96.9% below the Agriculture industry median of 72.70. Indo US Bio-Tech's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Days Payable is 2.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹87.82 is trading 71.8% below its estimated GF Value™ of ₹311.42.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Days Payable: 2.22 (96% below median its 10-year median of 50.63)
GF Value™: ₹311.42 vs. price of ₹87.82 (71.8% below fair value)
Industry Position: 96.9% below the Agriculture median (#241 of 244)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
69GF Score
Get the complete analysis for NSE:INDOUS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
